The objective ofthe newly-formed Joslin Advanced Genomics and Genetics Core (AGGC) is to provide support to Joslin and external investigators for the study of genome-based mechanisms of disease, by providing equipment, expertise, and services in nucleic acid analysis that would be too specialized or costly for individual laboratories to perform independently. The AGGC originates from the merging of the Joslin Genomics and Genetics Cores in response to the evolving scientific and technological landscape based on (1) the recognition that gene expression changes are mostly responsible for genetic predisposition to complex disorders and (2) the advent of new sequencing technologies providing a unified framework for DNA and RNA studies. The new Core will continue to provide the services previously offered by the two parent Cores, namely DNA extraction from blood, access to DNA collections from the Core's repository, SNP genotyping, and support for gene expression studies based on both high-density oligonucleotide arrays and real-time quantitative PCR. However, its defining objective will be to serve as an interface between Joslin investigators and next-generation sequencing by providing assistance with the complex protocols that must be accomplished in order to generate ready-to-sequence samples and which are often a barrier to sequencing approaches. Specifically, Core personnel will prepare sequencing libraries on behalf of Joslin investigators, will provide a next-generation sequencing service for projects requiring relatively low output, will facilitate investigators'access to external high-output next-generation sequencing platforms for larger projects, and will provide study design and analytical assistance in collaboration with the Boston University- Joslin Regional Computational (BUJRC) Core. Availability of these novel services will facilitate the ongoing transition of Joslin investigators to next-generation genomic methodologies, enhancing their productivity and increasing the cost-effectiveness of their research.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-S)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Joslin Diabetes Center
United States
Zip Code
Mezza, Teresa; Sorice, Gian P; Conte, Caterina et al. (2016) β-Cell Glucose Sensitivity Is Linked to Insulin/Glucagon Bihormonal Cells in Nondiabetic Humans. J Clin Endocrinol Metab 101:470-5
Shirakawa, J; Kulkarni, R N (2016) Novel factors modulating human β-cell proliferation. Diabetes Obes Metab 18 Suppl 1:71-7
Bonner-Weir, Susan; Aguayo-Mazzucato, Cristina (2016) Physiology: Pancreatic β-cell heterogeneity revisited. Nature 535:365-6
Hettmer, Simone; Lin, Michael M; Tchessalova, Daria et al. (2016) Hedgehog-driven myogenic tumors recapitulate skeletal muscle cellular heterogeneity. Exp Cell Res 340:43-52
Kokoye, Yasin; Ivanov, Ivan; Cheng, Qiufang et al. (2016) A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation. Thromb Res 140:118-24
Vegas, Arturo J; Veiseh, Omid; Doloff, Joshua C et al. (2016) Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates. Nat Biotechnol 34:345-52
Khamaisi, Mogher; Katagiri, Sayaka; Keenan, Hillary et al. (2016) PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblasts. J Clin Invest 126:837-53
Garvey, Katharine C; Telo, Gabriela H; Needleman, Joseph S et al. (2016) Health Care Transition in Young Adults With Type 1 Diabetes: Perspectives of Adult Endocrinologists in the U.S. Diabetes Care 39:190-7
Bonner-Weir, Susan; Aguayo-Mazzucato, Cristina; Weir, Gordon C (2016) Dynamic development of the pancreas from birth to adulthood. Ups J Med Sci 121:155-8
Ogawa, Takahiro; Kodera, Yukihiro; Hirata, Dai et al. (2016) Natural thioallyl compounds increase oxidative stress resistance and lifespan in Caenorhabditis elegans by modulating SKN-1/Nrf. Sci Rep 6:21611

Showing the most recent 10 out of 933 publications